[1] 徐波,蒋琰,张万年,等. 抗真菌药物靶标及其抑制剂的研究进展[J]. 药学实践杂志,2013,31(5):321-325.
[2] Pemán J, Salavert M, Cantón E, et al. Voriconazole in the management of nosocomial invasive fungal infections[J]. Therapeut Clinic Risk Manag, 2006, 2(2):129.
[3] 倪生良,沈荣明,夏平,等. 三唑类抗真菌药物伏立康唑的合成[J]. 精细石油化工,2006, 23(4):33-36.
[4] Miller JL, Schell WA, Wills EA, et al. In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans[J]. Antimicrob Agent Chemother, 2004, 48(2):384-387.
[5] Yu S, Wang L, Wang Y, et al. Molecular docking, design, synthesis and antifungal activity study of novel triazole derivatives containing 1, 2, 3-triazole group[J]. RSC Adv,2013, 3(3),13486-13490.
[6] Ichikawa T, Yamada M, Yamaguchi M, et al. Optically active antifungal azoles. XⅢ. Synthesis of Stereoisomers and Metabolites of 1-[(1R, 2R)-2-(2, 4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1, 2, 4-triazol-1-yl) propyl]-3-[4-(1H-1-tetrazolyl) phenyl]-2-imidazolidinone(TAK-456)[J]. Chemic Pharmaceut Bull, 2001, 49(9):1110-1119.
[7] Cao X, Sun Z, Cao Y, et al. Design, synthesis, and structure activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility[J]. J Med Chem, 2014, 57(9):3687-3706.
[8] 梁文杰,钟宏,何谋海. 乙氧基羰基异硫氰酸酯的合成工艺[J]. 化工进展,2011, 30(S1):610-612.
[9] 张春华,严云良.医药用数理统计[M].北京:科学出版社,2001:205.